David T. Doherty - 13 Mar 2023 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Financial Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Issuer symbol
SGRY
Transactions as of
13 Mar 2023
Transactions value $
-$104,029
Form type
4
Filing time
15 Mar 2023, 17:20:32
Previous filing
06 Mar 2023
Next filing
01 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale -$20.4K -682 -0.82% $29.86 82.4K 13 Mar 2023 Direct F1
transaction SGRY Common Stock Sale -$83K -2.67K -3.24% $31.11 79.8K 14 Mar 2023 Direct F2, F3
transaction SGRY Common Stock Sale -$632 -21 -0.03% $30.11 79.7K 15 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 10, 2023.
F2 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2023.
F3 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.